Vnitr Lek 2020, 66(4):236-241 | DOI: 10.36290/vnl.2020.067

Secondary prevention after acute coronary syndrome

Ján Murín¹, Jozef Bulas¹, Ľudovít Gašpar^1,4, Alexander Klabník², Martin Wawruch³

¹ I. interná klinika LF UK a UN Bratislava, Slovenská republika

² Kardiologická ambulancia, Oravská poliklinika, Námestovo, Slovenská republika

³ Ústav farmakológie a klinickej farmakológie LF UK Bratislava, Slovenská republika

⁴ Inštitút fyzioterapie, balneológie a liečebnej rehabilitácie Piešťany, Univerzita sv. Cyrila a Metoda v Trnave

Patients suffering acute coronary syndrome have a very high risk for a repeated syndrome. After stabilization of acute coronary syndrome and discharge of a patient it is important to educate the patient how to prevent it in the future (dietary and life style changes), but treatment of all cardiovascular risk factors/diseases, as hypertension, dyslipidemia, diabetes but stabilization of all cardiovascular diseases is also important. Important is also antithrombotic treatment (mostly double antiplatelet treatment when percutaneous coronary intervention was used with a coronary stents), RAAS blockers, betablockers and statins (strong as atorvastatin and rosuvastatin in the highest possible dose). There are also new risk factors, and vascular inflammation belongs here. We have nowadays also some successful clinical studies how to block inflammation and how to use this treatment. A good secondary cardiovascular prevention is able to improve enourmously prognosis of these patients

Keywords: acute coronary syndrome, cardiovascular risk factors, secondary cardiovascular prevention, vascular inflammation.

Published: June 1, 2020  Show citation